(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)

(Cost-)effectiveness of an individualised risk prediction tool (PERSARC) on patient’s knowledge and decisional conflict among soft-tissue sarcomas patients: protocol for a parallel cluster randomised trial (the VALUE-PERSARC study)

Introduction Current treatment decision-making in high-grade soft-tissue sarcoma (STS) care is not informed by individualised risks for different treatment options and patients’ preferences. Risk prediction tools may provide patients and professionals insight in personalised risks and benefits for d...

Full description

Bibliographic Details
Main Authors: Cornelis Verhoef, Rick L Haas, Elske M van den Akker-van Marle, Leti van Bodegom-Vos, Michiel A J van de Sande, Ellen G Engelhardt, Perla Marang-van de Mheen, Anouk A Kruiswijk, Yvonne M Schrage, Robert J van Ginkel, Han Bonenkamp, Marc HA Bemelmans, Ibtissam Acem, Stefanie Hakkesteegt, Roos F Bleckman, Marloes van Duijvenbode, Nicolette Leijerzapf, Jos A van der Hage, Robert J.P. van der Wal
Format: Article
Language:English
Published: BMJ Publishing Group 2023-11-01
Series:BMJ Open
Online Access:https://bmjopen.bmj.com/content/13/11/e074853.full

Internet

https://bmjopen.bmj.com/content/13/11/e074853.full

Similar Items